H19 and Hyperglycemia: Therapy delivery of LncRNA-H19-exo dramatically accelerated wound healing, indicating that LncRNA-H19-exo has the potential to counteract hyperglycemia and limit vascular regeneration, giving an efficient therapeutic impact on diabetic wounds (Tao et al., 2018).